Form 4: Lemaitre Vascular Director Roberts Acquires Dividend Equivalent Rights

David B. Roberts, a director and officer of Lemaitre Vascular, acquired dividend equivalent rights related to restricted stock unit and performance share unit awards.

Summary

• David B. Roberts, President and Director of Lemaitre Vascular Inc. [LMAT], reported the acquisition of dividend equivalent rights on May 30, 2024.
• These rights are associated with restricted stock unit (RSU) and performance share unit (PSU) awards previously granted to Roberts.
• The dividend equivalent rights vest proportionately with the underlying awards and are economically equivalent to shares of Lemaitre Vascular's common stock.
• The acquisitions include 0.746 rights related to a 2019 RSU award, 1.4054 rights related to a 2020 RSU award, 2.6743 rights related to a 2021 RSU award, 4.0868 rights related to a 2022 RSU award, 4.0868 rights related to a 2022 PSU award, and 4.6567 rights related to a 2023 RSU award.
• The prices of the derivative securities are all reported as $0.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to executive compensation.

Positives

• The acquisition of dividend equivalent rights suggests continued alignment of the director's interests with those of the shareholders.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The acquisition of dividend equivalent rights is a common practice for aligning executive compensation with shareholder returns.

Stakeholder Impact

• The acquisition of dividend equivalent rights aligns management's interests with shareholders, potentially encouraging decisions that benefit shareholders.

Key Dates